US2013123212A1PendingUtilityA1

Anti-fatigue composition, formulation and use thereof

Assignee: XU CHANGJIANGPriority: Jul 27, 2010Filed: Jul 27, 2011Published: May 16, 2013
Est. expiryJul 27, 2030(~4 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 35/00A61P 39/00A61P 39/06A61P 25/24A61K 9/2018A61K 47/10A61K 36/815A61K 9/4858A61K 31/715A61K 9/1623A61K 9/08A23V 2200/31A61P 25/00A61K 31/575A23L 33/10A23V 2002/00
29
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An anti-fatigue composition consisting of 20(S)-protopanoxadiol and lycium barbarum polysaccharide. Experiments prove that the composition exhibits a significant anti-fatigue effect. In comparison with the effect attained by the single use of lycium barbarum polysaccharide or 20(S)-protopanoxadiol, the combined use of 20(S)-protopanoxadiol and lycium barbarum polysaccharide exerts an obvious a clear synergistic effect.

Claims

exact text as granted — not AI-modified
1 . An anti-fatigue composition consisting of 20(S)-protopanoxadiol and  lycium barbarum  polysaccharide. 
     
     
         2 . The composition according to  claim 1 , wherein the weight ratio of the 20(S)-protopanoxadiol and  lycium barbarum  polysaccharide is 1:50 to 1:1000. 
     
     
         3 . A formulation comprising the composition according to  claim 1 , wherein the formulation consists of 20(S)-protopanoxadiol,  lycium barbarum  polysaccharide and pharmaceutically acceptable excipients. 
     
     
         4 . The formulation according to  claim 3 , wherein the formulation is in form of tablets, pills, capsules, granules or oral solution. 
     
     
         5 . A method for relieving fatigue, comprising administering the composition of  claim 1  to a subject. 
     
     
         6 . A method for relieving fatigue, comprising administering the formulation of  claim 3  to a subject. 
     
     
         7 . The method of  claim 5 , wherein the fatigue results from various causes. 
     
     
         8 . The method of  claim 7 , wherein the fatigue results from diseases. 
     
     
         9 . The method of  claim 8 , wherein the fatigue results from cancer or depression. 
     
     
         10 . (canceled) 
     
     
         11 . The composition according to  claim 1 , wherein the weight ratio of the 20(S)-protopanoxadiol and  lycium barbarum  polysaccharide is 0.01-50 to 60-480. 
     
     
         12 . The composition according to  claim 11 , wherein the weight ratio of the 20(S)-protopanoxadiol and  lycium barbarum  polysaccharide is 0.01-5 to 120-480. 
     
     
         13 . The formulation according to  claim 3 , wherein the weight ratio of the 20(S)-protopanoxadiol and  lycium barbarum  polysaccharide is 0.01-50 to 60-480. 
     
     
         14 . The formulation according to  claim 13 , wherein the weight ratio of the 20(S)-protopanoxadiol and  lycium barbarum  polysaccharide is 0.01-5 to 120-480.

Join the waitlist — get patent alerts

Track US2013123212A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.